|
KMID : 1030220230240030148
|
|
Journal of Korean Diabetes
2023 Volume.24 No. 3 p.148 ~ p.153
|
|
|
Characteristics of the Latest Therapeutic Agent for Diabetes
|
|
Yun Nu-Ri
|
|
|
Abstract
|
|
|
|
The latest therapeutic agent for diabetes is characterized by a longer lasting blood glucose control effect than existing treatments and stable blood glucose control. In addition, it has the advantage of being able to manage not only diabetes, but also comorbidities by considering the characteristics of each patient, such as comorbidities (atherosclerotic cardiovascular disease, chronic kidney disease, etc.). In this chapter, new antidiabetic drugs will be introduced based on the latest clinical research results on drugs such as sodium glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists.
|
|
|
KEYWORD
|
|
|
Glucagon-like peptide-1 receptor, Hypoglycemic agents, Sodium-glucose transporter 2 inhibitors
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|